Keywords: octreotide, implant, sees, 6-month, efficacy, usa, indevus

Octreotide implant sees 6-month efficacy

Article | 10 December 2007

Print This

The USA's Indevus Pharmaceuticals has reported positive results from a Phase II trial of its octreotide implant in patients with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in